the results demonstrated RRM2 gene expression was higher in lung cancer, colorectal cancer, breast cancer, bladder cancer, sarcoma cancer, liver cancer, and others than in their matched adjacent normal tissues. This evidence concerns the gene RRM2 and urinary bladder carcinoma.